• Calculator
  • T
  • N
  • M
  • Stage

American College of Chest Physicians (ACCP)

ACCP Vision: The ACCP is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. The ACCP is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care.

ACCP Mission: To champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research.

The American College of Chest Physicians is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. With more than 18,700 members representing 100+ countries around the world, the ACCP mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. This includes connecting health-care professionals to the latest clinical research and a wide array of evidence-based guidelines through the CHEST Journal, while also serving as a total education resource for clinicians through year-round meetings, books, mobile apps, and live courses in pulmonary, critical care, and sleep medicine. The first medical association with a clinical simulation program accredited by the Society for Simulation in Healthcare, the ACCP also provides hands-on training through innovative simulation education. The CHEST Foundation, the philanthropic arm of the ACCP, provides members with grants, patient education tools, and other resources to help their patients live and breathe easier.

Visit the ACCP's Web site.
Read CHEST Journal.
Learn more about The CHEST Foundation's OneBreath campaign.


Smilow Cancer Hospital at Yale-New Haven

A hallmark of the Yale Thoracic Oncology Program (TOP) is the close multispecialty interaction that results in decision-making based on collective knowledge and judgment. This is increasingly important as lung cancer care becomes more and more complex. This complexity is also evident in the 7th edition of the lung cancer stage classification, which is something that even an experienced group such as the Yale TOP team need help to remember.

In keeping with the Yale TOP program’s commitment to using technology and science to optimize care the TOP team set out to develop an interactive tool, available on the go, to navigate the intricacies of the new stage classification. This project was conceived and led by Anthony W, Kim MD with assistance from Frank Detterbeck MD, but represents a collective effort of the entire TOP team. The project benefitted from an outstanding collaborative relationship with the American College of Chest Physicians and the technologic expertise of SiNae Pitts Ph.D. CEO of Amphetamobile. We hope this is of value to you as it has been for us.

Thoracic Oncology Program Team at Yale


Amphetamobile

Amphetamobile sprang from the desire to build user-friendly online and mobile tools to further science, technology and medicine. Founded by SiNae Pitts, PhD, our passion is for creating user-centric, elegant technology that features the highest quality content, is online, mobile and good for the world.

Amphetamobile is a one-stop shop for web, mobile web, and native mobile application development, design, and consulting. AMMO, for short, has developed mobile publishing platforms for periodical, textbook, image bank, and Q/A content, which are customized and developed in partnership with leading international publishers. We are particularly proud of our long standing relationship with ACCP, who have been a front-running society in delivering scholarly, educational and certification content on mobile. ACCP's leadership and support for developing new tools such as this microsite, helps clinicians and students make meaningful use of these traditionally published lung cancer staging guidelines. Facilitating experts, such as Drs. Anthony Kim and Frank Detterbeck, to compose new tools, calculators and sites, and AMMO to bring them to life, will do much for the dissemination of knowledge and the future of medicine that is evidence based, expertly edited and reviewed, and professionally and thoughtfully designed and delivered. We all welcome your thoughts and feedback on the microsite, which you can send to: staginglungcancer@amphetamobile.com

Amphetamobile Web site